The American Cancer Society, which distributes cancer screening kits to hundreds of hospitals and other healthcare providers across the country, has become a major source of revenue for the institute, which has been criticized for charging patients hundreds of dollars for the service.
The organization has been at the center of a controversy over fees that have been blamed for keeping cancer screenings low in the United States and abroad.
The American Association of Cancer Research, which represents the nation’s cancer experts, has said that the institute has not met the standards set by the organization and that it has been unfair to the millions of people who have relied on its services to determine whether they are cancer free.
The ACS has said the fee system is not in line with other medical centers that have offered similar services, such as hospitals and nursing homes.
In a statement on Tuesday, the ACS said the organization was working to reform the fees it charges for screenings.
The cancer institute is the largest provider of cancer screening tests in the country.
It is one of the nation “top” providers of screening tests, the American Cancer Research statement said.
The association is calling on the ACS to “rethink” its fees.
The fees are estimated to cost between $20 and $50 per test, depending on the test.
The institute charges $75 for a single test, according to its website.
The fee structure for the cancer screenings was first reported by The Washington Times.
The newspaper reported in February that the ACS charges $15,000 for the screening, a figure that was not disclosed by the ACS.
The group also charges $2,000 to $5,000 per test for a cancer test.
On its website, the cancer group says that the fee structure is “in keeping with a global approach to cost-effectiveness” and that the costs of screening and follow-up care are borne by patients, the community, and the government.
The statement issued by the American Association said that it is “appalled” by the comments of a number of individuals who have said the fees are unfair to patients and are a barrier to accessing the services.
“While the ACS has consistently provided quality cancer screenings to millions of Americans, its fees have been seen as unfairly charging patients for such services and unfairly keeping patients from getting the care they need,” the statement said, referring to the ACS’s website.
“This is unacceptable.
The agency must change its fee structure to reflect a cost-effective approach to cancer care.”
The ACS said that its fee policies are in line “with the global approach.”
The agency said that while it would like to see the fee changes that the American Society for Cancer Research recommends to the agency, the fee is “not the only cost that we charge.”
It said that in its most recent annual report, ACS estimated that the fees for the tests ranged from $2.6 million for the mammography test to $1.9 million for a colonoscopy test.
ACS said its annual reports were based on an average of the fees charged by providers, hospitals and private insurers.
The Associated Press first reported the statement from the ACS on Tuesday.
A person familiar with the matter said that ACS officials had no comment on the AP’s report.
The AP was unable to reach the ACS for comment.
The Washington Examiner first reported on the American association statement.